Exact Mass: 263.16739060000003

Exact Mass Matches: 263.16739060000003

Found 117 metabolites which its exact mass value is equals to given mass value 263.16739060000003, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Nortriptyline

methyl({3-[(2E)-tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene]propyl})amine

C19H21N (263.16739060000003)


Nortriptyline is an organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline. It has a role as a drug metabolite, an antidepressant, an adrenergic uptake inhibitor, an analgesic, an antineoplastic agent and an apoptosis inducer. It is an organic tricyclic compound and a secondary amine. It is functionally related to an amitriptyline. It derives from a hydride of a dibenzo[a,d][7]annulene. Nortriptyline hydrochloride, the active metabolite of [amitriptyline], is a tricyclic antidepressant (TCA). It is used in the treatment of major depression and is also used off-label for chronic pain and other conditions. Nortriptyline is a Tricyclic Antidepressant. Nortriptyline is a tricyclic antidepressant that is also used in smoking cessation. Nortriptyline can cause mild and transient serum enzyme elevations and is rare cause of clinically apparent acute and chronic cholestatic liver injury. Nortriptyline is a natural product found in Senegalia berlandieri with data available. Nortriptyline is a tricyclic antidepressant agent used for short-term treatment of various forms of depression. Nortriptyline blocks the norepinephrine presynaptic receptors, thereby blocking the reuptake of this neurotransmitter and raising the concentration in the synaptic cleft in the CNS. Nortriptyline also binds to alpha-adrenergic, histaminergic and cholinergic receptors. Long-term treatment with nortriptyline produces a downregulation of adrenergic receptors due to the increased stimulation of these receptors. Nortriptyline hydrochloride, the N-demethylated active metabolite of amitriptyline, is a dibenzocycloheptene-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, nortriptyline does not affect mood or arousal, but may cause sedation. In depressed individuals, nortriptyline exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. Secondary amine TCAs, such as nortriptyline, are more potent inhibitors of norepinephrine reuptake than tertiary amine TCAs, such as amitriptyline. TCAs also down-regulate cerebral cortical β-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine-H1 receptors, α1-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects (e.g. blurred vision, dry mouth, constipation, urinary retention), respectively. See toxicity section below for a complete listing of side effects. Nortriptyline exerts less anticholinergic and sedative side effects compared to the tertiary amine TCAs, amitriptyline and clomipramine. Nortriptyline may be used to treat depression, chronic pain (unlabeled use), irritable bowel syndrome (unlabeled use), diabetic neuropathy (unlabeled use), post-traumatic stress disorder (unlabeled use), and for migraine prophylaxis (unlabeled use). A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions. See also: Nortriptyline Hydrochloride (active moiety of). Nortriptyline hydrochloride, the N-demethylated active metabolite of amitriptyline, is a dibenzocycloheptene-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, nortriptyline does not affect mood or arousal, but may cause sedation. In depressed individuals, nortriptyline exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. Secondary amine TCAs, such as nortriptyline, are more potent inhibitors of norepinephrine reuptake than tertiary amine TCAs, such as amitriptyline. TCAs also down-regulate cerebral cortical β-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine-H1 receptors, α1-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects (e.g. blurred vision, dry mouth, constipation, urinary retention), respectively. See toxicity section below for a complete listing of side effects. Nortriptyline exerts less anticholinergic and sedative side effects compared to the tertiary amine TCAs, amitriptyline and clomipramine. Nortriptyline may be used to treat depression, chronic pain (unlabeled use), irritable bowel syndrome (unlabeled use), diabetic neuropathy (unlabeled use), post-traumatic stress disorder (unlabeled use), and for migraine prophylaxis (unlabeled use). An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline. N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators CONFIDENCE standard compound; EAWAG_UCHEM_ID 3692 Nortriptyline (Desmethylamitriptyline), the main active metabolite of Amitriptyline, is a tricyclic antidepressant. Nortriptyline is a potent autophagy inhibitor and has anticancer effects[1][2][3]. N

   

Protriptyline

methyl(3-{tricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-yl}propyl)amine

C19H21N (263.16739060000003)


Protriptyline hydrochloride is a dibenzocycloheptene-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, protriptyline does not affect mood or arousal, but may cause sedation. In depressed individuals, protriptyline exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. In addition, TCAs down-regulate cerebral cortical β-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine H1 receptors, α1-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects (e.g. blurred vision, dry mouth, constipation, urinary retention), respectively. See toxicity section below for a complete listing of side effects. Protriptyline may be used for the treatment of depression. N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators

   

2-Ethyl-5-methyl-3,3-diphenyl-1-pyrroline

5-ethyl-2-methyl-4,4-diphenyl-3,4-dihydro-2H-pyrrole

C19H21N (263.16739060000003)


2-Ethyl-5-methyl-3,3-diphenyl-1-pyrroline is a metabolite of methadone. Methadone (also known as Symoron, Dolophine, Amidone, Methadose, Physeptone, Heptadon, Phy and many other names) is a synthetic opioid, used medically as an analgesic and a maintenance anti-addictive for use in patients with opioid dependency. It was developed in Germany in 1937. Although chemically unlike morphine or heroin, methadone acts on the same opioid receptors as these drugs, and thus has many of the same effects. (Wikipedia)

   

Axisothiocyanate 3

Axisothiocyanate 3

C16H25NS (263.170761)


   

Hydroxyvalerylcarnitine

Hydroxyvalerylcarnitine

C12H25NO5 (263.173264)


Hydroxyvalerylcarnitine is an acylcarnitine. More specifically, it is an hydroxyvaleric acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Hydroxyvalerylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine hydroxyvalerylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular hydroxyvalerylcarnitine is elevated in the blood or plasma of individuals with 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency (PMID: 28583327) and holocarboxylase synthetase deficiency (PMID: 27114915). It is also decreased in the blood or plasma of individuals with psoriasis (PMID: 33391503). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

demethylmaprotiline

3-{tetracyclo[6.6.2.0²,⁷.0⁹,¹⁴]hexadeca-2,4,6,9,11,13-hexaen-1-yl}propan-1-amine

C19H21N (263.16739060000003)


demethylmaprotiline is a metabolite of maprotiline. Maprotiline (sold as Deprilept, Ludiomil, Psymion) is a tetracyclic antidepressant (TeCA). However, Maprotilines fourth ring is spurious, as formed by a bridge across the central tricyclic ring. It is a strong norepinephrine reuptake inhibitor with only weak effects on serotonin and dopamine reuptake. (Wikipedia)

   

Gacyclidine

1-[2-methyl-1-(thiophen-2-yl)cyclohexyl]piperidine

C16H25NS (263.170761)


   

Melperone

1-(4-fluorophenyl)-4-(4-methylpiperidin-1-yl)butan-1-one

C16H22FNO (263.1685334)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

10alpha-Isothiocyanatoalloaromadendrane

10alpha-Isothiocyanatoalloaromadendrane

C16H25NS (263.170761)


   

Axisothiocyanate 1

(1R,3aR,7aR)-Octahydro-1-[(1S)-1-isothiocyanato-2-methylpropyl]-3a-methyl-7-methylene-1H-indene

C16H25NS (263.170761)


   

Acanthisothiocyanate 3

Acanthisothiocyanate 3

C16H25NS (263.170761)


   

Axinisothiocyanate K

Axinisothiocyanate K

C16H25NS (263.170761)


   

6-Isodaucene 14-isothiocyanate

6-Isodaucene 14-isothiocyanate

C16H25NS (263.170761)


   

10-Isothiocyanatoguai-6-ene

10-Isothiocyanatoguai-6-ene

C16H25NS (263.170761)


   
   

Theonellin isothiocyanate

Theonellin isothiocyanate

C16H25NS (263.170761)


   

Epipolasin A

(1aR,3aS,7S,7aS,7bR)-Decahydro-7-isothiocyanato-1,1,3a,7-tetramethyl-1H-cyclopropa[a]naphthalene

C16H25NS (263.170761)


   

1-Isothiocyanato-4-muurolene

1-Isothiocyanato-4-muurolene

C16H25NS (263.170761)


   

Axinythiocyanate A

Axinythiocyanate A

C16H25NS (263.170761)


   

1-Isothiocyanatoaromadendrane

1-Isothiocyanatoaromadendrane

C16H25NS (263.170761)


   

7-isothiocyanato-7,8-dihydro-alpha-bisabolene

7-isothiocyanato-7,8-dihydro-alpha-bisabolene

C16H25NS (263.170761)


   

4-fluoro-alpha-pyrrolidinohexanophenone

4-fluoro-alpha-pyrrolidinohexanophenone

C16H22FNO (263.1685334)


   

MELPERONE

MELPERONE

C16H22FNO (263.1685334)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

4-thiocyanatoneopupukeanane

4-thiocyanatoneopupukeanane

C16H25NS (263.170761)


   

Axisothiocyanate 2

Axisothiocyanate 2

C16H25NS (263.170761)


   

5-isothiocyanatopupukeanane

5-isothiocyanatopupukeanane

C16H25NS (263.170761)


   

11-isothiocyano-7beta-H-eudesm-5-ene|11-isothiocyano-7betaH-eudesm-5-ene

11-isothiocyano-7beta-H-eudesm-5-ene|11-isothiocyano-7betaH-eudesm-5-ene

C16H25NS (263.170761)


   

(-)-cavernothiocyanate|cavernothiocyanate

(-)-cavernothiocyanate|cavernothiocyanate

C16H25NS (263.170761)


   

(2R,5R,10S)-2-isothiocyanto-6-axene

(2R,5R,10S)-2-isothiocyanto-6-axene

C16H25NS (263.170761)


   

rel-(1S,3aS,4S,8aR)-4-isothiocyanato-3a,7-dimethyl-1,2,3,3a,4,5,6,8a-octahydro-1-(prop-2-yl)azulene|rel-4,5-epi-10-isothiocyanatoisodauc-6-ene

rel-(1S,3aS,4S,8aR)-4-isothiocyanato-3a,7-dimethyl-1,2,3,3a,4,5,6,8a-octahydro-1-(prop-2-yl)azulene|rel-4,5-epi-10-isothiocyanatoisodauc-6-ene

C16H25NS (263.170761)


   

4alpha-isothiocyanatogorgon-11-ene|4alpha-isothiocyanogorgon-11-ene

4alpha-isothiocyanatogorgon-11-ene|4alpha-isothiocyanogorgon-11-ene

C16H25NS (263.170761)


   

9-thiocyanatopupukeanane

9-thiocyanatopupukeanane

C16H25NS (263.170761)


   

(1R*,2R*,3R*,5R*,6S*,7S*)-2-Thiocyanatopupukeanane

(1R*,2R*,3R*,5R*,6S*,7S*)-2-Thiocyanatopupukeanane

C16H25NS (263.170761)


   

rel-(1S,2S,5S,6S,7R,8S)-13-isothiocyanatocubebane

rel-(1S,2S,5S,6S,7R,8S)-13-isothiocyanatocubebane

C16H25NS (263.170761)


   

(1S*,4S*,6S*,7R*)-4-thiocyanato-9-cadinene

(1S*,4S*,6S*,7R*)-4-thiocyanato-9-cadinene

C16H25NS (263.170761)


   

9-isothiocyanatopupukeanane

9-isothiocyanatopupukeanane

C16H25NS (263.170761)


   

(-)-Epipolasin A

(-)-Epipolasin A

C16H25NS (263.170761)


   

(4beta,7betaH)-12-Isothiocyanato-5-eudesmene

(4beta,7betaH)-12-Isothiocyanato-5-eudesmene

C16H25NS (263.170761)


   

6-deoxy-6-C-(2,5-dihydroxyhexyl)-2(R),5(R)-bis(hydroxymethyl)-3(R),4(R)-dihydroxypyrrolidine

6-deoxy-6-C-(2,5-dihydroxyhexyl)-2(R),5(R)-bis(hydroxymethyl)-3(R),4(R)-dihydroxypyrrolidine

C12H25NO5 (263.173264)


   

farnesyl isothiocyanate

farnesyl isothiocyanate

C16H25NS (263.170761)


   

10-isothiocyanato-11-axene|7-Isothiocyanato-11-oppositene

10-isothiocyanato-11-axene|7-Isothiocyanato-11-oppositene

C16H25NS (263.170761)


   
   

Nortriptyline

Nortriptyline

C19H21N (263.16739060000003)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents CONFIDENCE standard compound; INTERNAL_ID 1567 D049990 - Membrane Transport Modulators Nortriptyline (Desmethylamitriptyline), the main active metabolite of Amitriptyline, is a tricyclic antidepressant. Nortriptyline is a potent autophagy inhibitor and has anticancer effects[1][2][3]. N

   

Melperon

MELPERONE

C16H22FNO (263.1685334)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent CONFIDENCE standard compound; INTERNAL_ID 2513 CONFIDENCE standard compound; INTERNAL_ID 8494

   

protriptyline

protriptyline

C19H21N (263.16739060000003)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators

   
   

2-thiocyanatopupukeanane [C16H25NS]

2-thiocyanatopupukeanane [C16H25NS]

C16H25NS (263.170761)


   

5-isothiocyanato [C16H25N]

5-isothiocyanato [C16H25N]

C16H25NS (263.170761)


   

Isothiocyanato-4-amorphene [C16H25NS]

Isothiocyanato-4-amorphene [C16H25NS]

C16H25NS (263.170761)


   

1-isothiocyanato [C16H25NS]

1-isothiocyanato [C16H25NS]

C16H25NS (263.170761)


   

4-thiocyanatopupukeanane [C16H25NS]

4-thiocyanatopupukeanane [C16H25NS]

C16H25NS (263.170761)


   

10-isothiocyanato-4-amorphene [C16H25NS]

10-isothiocyanato-4-amorphene [C16H25NS]

C16H25NS (263.170761)


   

11-Isothiocyano-7bH-eudesm-5-ene [C16H25NS]

11-Isothiocyano-7bH-eudesm-5-ene [C16H25NS]

C16H25NS (263.170761)


   
   
   

1-Isothiocyano-4-amorphene [C16H25NS]

1-Isothiocyano-4-amorphene [C16H25NS]

C16H25NS (263.170761)


   

2-Amino-N-(3-morpholin-4-ylpropyl)benzamide

2-Amino-N-(3-morpholin-4-ylpropyl)benzamide

C14H21N3O2 (263.1633686)


   

2-Isoproxypyridine-4-boronic acid pinacol ester

2-Isoproxypyridine-4-boronic acid pinacol ester

C14H22BNO3 (263.16926520000004)


   

2-Isopropoxy-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine

2-Isopropoxy-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine

C14H22BNO3 (263.16926520000004)


   

8-N-BOC-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-METHYLAMINE

8-N-BOC-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-METHYLAMINE

C14H21N3O2 (263.1633686)


   

8-Amino-4-Boc-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine

8-Amino-4-Boc-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine

C14H21N3O2 (263.1633686)


   

1-N-ALLYL-3-PHENYL-2,3,4,5-TERAHYDRO-BENZO(D)AZEPINE

1-N-ALLYL-3-PHENYL-2,3,4,5-TERAHYDRO-BENZO(D)AZEPINE

C19H21N (263.16739060000003)


   

1-PIPERAZINECARBOXYLIC ACID, 4-(2-PYRIDINYL)-, 1,1-DIMETHYLETHYL ESTER

1-PIPERAZINECARBOXYLIC ACID, 4-(2-PYRIDINYL)-, 1,1-DIMETHYLETHYL ESTER

C14H21N3O2 (263.1633686)


   

5-AMINO-3-OXO-2,3-DIHYDRO-1H-PYRAZOLE-4-CARBOXYLIC ACID

5-AMINO-3-OXO-2,3-DIHYDRO-1H-PYRAZOLE-4-CARBOXYLIC ACID

C14H21N3O2 (263.1633686)


   

1-CBZ-4-(2-AMINOETHYL)PIPERAZINE

1-CBZ-4-(2-AMINOETHYL)PIPERAZINE

C14H21N3O2 (263.1633686)


   
   
   

1-Benzyl-4-(4-methylphenyl)tetrahydropyridine

1-Benzyl-4-(4-methylphenyl)tetrahydropyridine

C19H21N (263.16739060000003)


   

PIPERAZINE-1-CARBOXYLIC ACID (4-ISOPROPOXY-PHENYL)-AMIDE

PIPERAZINE-1-CARBOXYLIC ACID (4-ISOPROPOXY-PHENYL)-AMIDE

C14H21N3O2 (263.1633686)


   
   

[1-(2-amino-phenyl)-azetidin-3-yl]-carbamic acid tert-butyl ester

[1-(2-amino-phenyl)-azetidin-3-yl]-carbamic acid tert-butyl ester

C14H21N3O2 (263.1633686)


   

1-PIPERIDINECARBOXYLIC ACID, 3-(2-PYRIMIDINYL)-, 1,1-DIMETHYLETHYL ESTER

1-PIPERIDINECARBOXYLIC ACID, 3-(2-PYRIMIDINYL)-, 1,1-DIMETHYLETHYL ESTER

C14H21N3O2 (263.1633686)


   

4-(2-Pyrimidinyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester

4-(2-Pyrimidinyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester

C14H21N3O2 (263.1633686)


   

BENZYL (2-(PIPERAZIN-1-YL)ETHYL)CARBAMATE

BENZYL (2-(PIPERAZIN-1-YL)ETHYL)CARBAMATE

C14H21N3O2 (263.1633686)


   

Pinacidil hydrate

Pinacidil monohydrate

C13H21N5O (263.1746016)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D049990 - Membrane Transport Modulators

   

2-ISOPROPOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

2-ISOPROPOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

C14H22BNO3 (263.16926520000004)


   

2-Propoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

2-Propoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

C14H22BNO3 (263.16926520000004)


   

5-Isopropoxypyridine-3-boronic acid pinacol ester

5-Isopropoxypyridine-3-boronic acid pinacol ester

C14H22BNO3 (263.16926520000004)


   

tert-butyl 2-pyridin-2-ylpiperazine-1-carboxylate

tert-butyl 2-pyridin-2-ylpiperazine-1-carboxylate

C14H21N3O2 (263.1633686)


   

Hexyl [(4-aminophenyl)(imino)methyl]carbamate

Hexyl [(4-aminophenyl)(imino)methyl]carbamate

C14H21N3O2 (263.1633686)


   

2-Propoxypyridine-3-boronic acid pinacol ester

2-Propoxypyridine-3-boronic acid pinacol ester

C14H22BNO3 (263.16926520000004)


   

Ethyl 5-[(4-methylpiperazin-1-yl)-methyl]pyridine-2-carboxylate

Ethyl 5-[(4-methylpiperazin-1-yl)-methyl]pyridine-2-carboxylate

C14H21N3O2 (263.1633686)


   

7-Amino-4-Boc-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine

7-Amino-4-Boc-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine

C14H21N3O2 (263.1633686)


   

[1-(3-amino-phenyl)-azetidin-3-yl]-carbamic acid tert-butyl ester

[1-(3-amino-phenyl)-azetidin-3-yl]-carbamic acid tert-butyl ester

C14H21N3O2 (263.1633686)


   
   

buta-1,3-diene, styrene, 2-vinylpyridine

buta-1,3-diene, styrene, 2-vinylpyridine

C19H21N (263.16739060000003)


   

Gacyclidine

Gacyclidine

C16H25NS (263.170761)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents

   

Naphthalene, decahydro-1-isothiocyanato-4a-methyl-8-methylene-2-(1-methylethyl)-, (1alpha,2beta,4aalpha,8aalpha)-

Naphthalene, decahydro-1-isothiocyanato-4a-methyl-8-methylene-2-(1-methylethyl)-, (1alpha,2beta,4aalpha,8aalpha)-

C16H25NS (263.170761)


   

Ethyl 4-[(4-methylpyridin-2-yl)amino]piperidine-1-carboxylate

Ethyl 4-[(4-methylpyridin-2-yl)amino]piperidine-1-carboxylate

C14H21N3O2 (263.1633686)


   

4-Amino-2-hexyloxy-6-hydroxymethyl-tetrahydro-pyran-3,5-diol

4-Amino-2-hexyloxy-6-hydroxymethyl-tetrahydro-pyran-3,5-diol

C12H25NO5 (263.173264)


   

[2-(4-Amino-3-hydroxybutanoyl)oxy-3-carboxypropyl]-trimethylazanium

[2-(4-Amino-3-hydroxybutanoyl)oxy-3-carboxypropyl]-trimethylazanium

C11H23N2O5+ (263.1606888)


   

(3S)-3-(1,3-dihydroxypentoxy)-4-(trimethylazaniumyl)butanoate

(3S)-3-(1,3-dihydroxypentoxy)-4-(trimethylazaniumyl)butanoate

C12H25NO5 (263.173264)


   

N6-ethyl-N4-propan-2-yl-N2-(1,2,4-triazol-4-yl)-1,3,5-triazine-2,4,6-triamine

N6-ethyl-N4-propan-2-yl-N2-(1,2,4-triazol-4-yl)-1,3,5-triazine-2,4,6-triamine

C10H17N9 (263.1606842)


   

6-{(1S,5S)-4-oxo-5-[(2Z)-pent-2-en-1-yl]cyclopent-2-en-1-yl}hexanoate

6-{(1S,5S)-4-oxo-5-[(2Z)-pent-2-en-1-yl]cyclopent-2-en-1-yl}hexanoate

C16H23O3- (263.16471079999997)


   

N-propan-2-yl-2-[4-(2-pyrimidinyl)-1-piperazinyl]acetamide

N-propan-2-yl-2-[4-(2-pyrimidinyl)-1-piperazinyl]acetamide

C13H21N5O (263.1746016)


   

N-(1-Cyclopropylethyl)-2-methoxyaniline, TMS derivative

N-(1-Cyclopropylethyl)-2-methoxyaniline, TMS derivative

C15H25NOSi (263.170532)


   

2-Thiocyanatoneopupukeanane

2-Thiocyanatoneopupukeanane

C16H25NS (263.170761)


   

4-Amorphene-10-isothiocyanate

4-Amorphene-10-isothiocyanate

C16H25NS (263.170761)


   

EMDP

2-Ethyl-5-methyl-3,3-diphenyl-1-pyrroline

C19H21N (263.16739060000003)


   
   
   

(1r,4r,4ar,6s)-4-isopropyl-6-isothiocyanato-1,6-dimethyl-2,3,4,4a,5,7-hexahydro-1h-naphthalene

(1r,4r,4ar,6s)-4-isopropyl-6-isothiocyanato-1,6-dimethyl-2,3,4,4a,5,7-hexahydro-1h-naphthalene

C16H25NS (263.170761)


   

7-isopropyl-2-isothiocyanato-2,10-dimethylspiro[4.5]dec-6-ene

7-isopropyl-2-isothiocyanato-2,10-dimethylspiro[4.5]dec-6-ene

C16H25NS (263.170761)


   

(2s,5r,10s)-7-isopropyl-2-isothiocyanato-2,10-dimethylspiro[4.5]dec-6-ene

(2s,5r,10s)-7-isopropyl-2-isothiocyanato-2,10-dimethylspiro[4.5]dec-6-ene

C16H25NS (263.170761)


   

7-(2-isothiocyanatopropan-2-yl)-1,4a-dimethyl-2,3,4,5,6,7-hexahydro-1h-naphthalene

7-(2-isothiocyanatopropan-2-yl)-1,4a-dimethyl-2,3,4,5,6,7-hexahydro-1h-naphthalene

C16H25NS (263.170761)


   

(5r,6s,7r,10s)-7-isopropyl-6-isothiocyanato-2,10-dimethylspiro[4.5]dec-1-ene

(5r,6s,7r,10s)-7-isopropyl-6-isothiocyanato-2,10-dimethylspiro[4.5]dec-1-ene

C16H25NS (263.170761)


   

[(2e)-3-[(1r,3ar,7r,7ar)-3a,7-dimethyl-octahydroinden-1-yl]-2-methylprop-2-en-1-yl]sulfanylcarbonitrile

[(2e)-3-[(1r,3ar,7r,7ar)-3a,7-dimethyl-octahydroinden-1-yl]-2-methylprop-2-en-1-yl]sulfanylcarbonitrile

C16H25NS (263.170761)


   

(1ar,4r,4as,7r,7as,7bs)-4-isothiocyanato-1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulene

(1ar,4r,4as,7r,7as,7bs)-4-isothiocyanato-1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulene

C16H25NS (263.170761)


   

7-isopropyl-6-isothiocyanato-2,10-dimethylspiro[4.5]dec-1-ene

7-isopropyl-6-isothiocyanato-2,10-dimethylspiro[4.5]dec-1-ene

C16H25NS (263.170761)


   

2-(3,6-dihydroxyheptyl)-5-(hydroxymethyl)pyrrolidine-3,4-diol

2-(3,6-dihydroxyheptyl)-5-(hydroxymethyl)pyrrolidine-3,4-diol

C12H25NO5 (263.173264)


   

(1r,3as,4s,8ar)-7-isopropyl-4-isothiocyanato-1,4-dimethyl-2,3,3a,5,6,8a-hexahydro-1h-azulene

(1r,3as,4s,8ar)-7-isopropyl-4-isothiocyanato-1,4-dimethyl-2,3,3a,5,6,8a-hexahydro-1h-azulene

C16H25NS (263.170761)


   

(1ar,4r,4as,7r,7ar,7br)-4-isothiocyanato-1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulene

(1ar,4r,4as,7r,7ar,7br)-4-isothiocyanato-1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulene

C16H25NS (263.170761)


   

(1s,3as,7as)-1-[(1s)-1-isothiocyanato-2-methylpropyl]-3a-methyl-7-methylidene-hexahydro-1h-indene

(1s,3as,7as)-1-[(1s)-1-isothiocyanato-2-methylpropyl]-3a-methyl-7-methylidene-hexahydro-1h-indene

C16H25NS (263.170761)


   

7-isopropyl-4-isothiocyanato-1,4-dimethyl-2,3,3a,5,6,8a-hexahydro-1h-azulene

7-isopropyl-4-isothiocyanato-1,4-dimethyl-2,3,3a,5,6,8a-hexahydro-1h-azulene

C16H25NS (263.170761)


   

(1ar,3as,7s,7as,7br)-7-isothiocyanato-1,1,3a,7-tetramethyl-octahydrocyclopropa[a]naphthalene

(1ar,3as,7s,7as,7br)-7-isothiocyanato-1,1,3a,7-tetramethyl-octahydrocyclopropa[a]naphthalene

C16H25NS (263.170761)